Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

Leukemia

Volumn 28, Issue 8, 2014, Pages 1738-1742

  Kontro, M ^a   Kuusanmaki H ^a   Eldfors, S ^a   Burmeister, T ^b   Andersson, E I ^a   Bruserud, O ^c,d   Brummendorf T H ^e   Edgren, H ^a   Gjertsen, B T ^c,d   Itala Remes M ^f   Lagstrom S ^a   Lohi, O ^g   Lundan T ^h   Marti J M L ^a   Majumder, M M ^a   Parsons, A ^a   Pemovska, T ^a   Rajala, H ^a   Vettenranta, K ^a   Kallioniemi, O ^a   Mustjoki, S ^a   Porkka, K ^a   Heckman, C A ^a,i   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BCL-X PROTEIN; HUMANS; MUTATION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT5 TRANSCRIPTION FACTOR;

EID: 84905675937     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.89     Document Type: Letter

References (15)

1. Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F, Towatari M et al. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis. Int J Hematol 2000; 71: 46-54.
2. Rajala HL, Eldfors S, Kuusanmaki H, van Adrichem AJ, Olson T, Lagstrom S et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood 2013; 121: 4541-4550.
3. De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 2013; 45: 186-190.
4. Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 2011; 43: 932-939.
5. Ribeiro D, Melao A, Barata JT. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia. Adv Biol Regul 2013; 53: 211-222.
6. Flex E, Petrangeli V, Stella L, Chiaretti S, Hornakova T, Knoops L et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008; 205: 751-758.
7. Bains T, Heinrich MC, Loriaux MM, Beadling C, Nelson D, Warrick A et al. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia 2012; 26: 2144-2146.
8. De Keersmaecker K, de Bock CE, Cools J. The biology of T-cell acute lymphoblastic leukemia. Hematology Education: the Education Program for the Annual Congress of the European Hematology Association, Vol 7, European Hematology Association, 2013, pp 1-7.
9. Takada K, Jameson SC. Naive T cell homeostasis: from awareness of space to a sense of place. Nat Rev Immunol 2009; 9: 823-832.
10. Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmaki H, Andersson EI et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366: 1905-1913.
11. Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A et al. Individualized Systems Medicine (ISM) strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia. Cancer Discov 2013; 3: 1416-1429.
12. Kelly JA, Spolski R, Kovanen PE, Suzuki T, Bollenbacher J, Pise-Masison CA et al. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J Exp Med 2003; 198: 79-89.
13. Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH et al. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discov 2013; 3: 564-577.
14. Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, Boussiotis VA. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 2004; 200: 659-669.
15. Nelson EA, Walker SR, Alvarez JV, Frank DA. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J Biol Chem 2004; 279: 54724-54730.